{"id":"amoxicillin-and-gentamicin","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Abdominal pain"},{"rate":"1-5%","effect":"Hypersensitivity reactions"}]},"_chembl":{"chemblId":"CHEMBL2105950","moleculeType":"Small molecule","molecularWeight":"387.39"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Amoxicillin works by binding to penicillin-binding proteins on the bacterial cell wall, preventing the formation of a functional cell wall and ultimately leading to cell lysis and death. Gentamicin, on the other hand, binds to the 30S subunit of the bacterial ribosome, interfering with protein synthesis and ultimately leading to bacterial death.","oneSentence":"Amoxicillin is a beta-lactam antibiotic that inhibits cell wall synthesis in bacteria, while gentamicin is an aminoglycoside antibiotic that interferes with bacterial protein synthesis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:01:23.643Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Community-acquired pneumonia"},{"name":"Skin and skin structure infections"}]},"trialDetails":[{"nctId":"NCT02701595","phase":"PHASE3","title":"Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2016-02-29","conditions":"Infective Endocarditis","enrollment":324},{"nctId":"NCT07236944","phase":"PHASE4","title":"Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care","status":"RECRUITING","sponsor":"Uppsala University","startDate":"2025-12","conditions":"Febrile Urinary Tract Infection","enrollment":560},{"nctId":"NCT07082465","phase":"","title":"Epidemiology of Antimicrobial-use and Antimicrobial-resistant Infections in Four Hospitals in Thailand","status":"NOT_YET_RECRUITING","sponsor":"University of Oxford","startDate":"2025-08-01","conditions":"Drug Resistance, Bacterial, Bacteremia","enrollment":108000},{"nctId":"NCT05929599","phase":"NA","title":"Efficacy of LiveSpo Navax in Supportive Treatment of Pneumonia in Children With RSV and Bacterial Co-infections","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Children's Hospital, Vietnam","startDate":"2023-07-05","conditions":"Acute Respiratory Tract Infections, Pneumonia, Respiratory Syncytial Virus (RSV)","enrollment":120},{"nctId":"NCT04755179","phase":"","title":"Identification of the Optimal Treatment Strategy for Complex Appendicitis in the Pediatric Population","status":"COMPLETED","sponsor":"Ramon Gorter","startDate":"2019-08-12","conditions":"Appendicitis, Appendix Mass, Appendicitis Perforated","enrollment":1308},{"nctId":"NCT04041791","phase":"PHASE3","title":"A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2019-08-19","conditions":"Pneumonia","enrollment":4392},{"nctId":"NCT02848820","phase":"PHASE4","title":"Initial Non-operative Treatment Strategy Versus Appendectomy Treatment Strategy for Simple Appendicitis in Children","status":"UNKNOWN","sponsor":"Ramon Gorter","startDate":"2016-12","conditions":"Appendicitis","enrollment":302},{"nctId":"NCT04438655","phase":"NA","title":"Prospective Randomized Clinical Trial on Oral and Intravenous Antibiotic Prophylaxis in Colorectal Surgery.","status":"COMPLETED","sponsor":"University of Turin, Italy","startDate":"2019-05-01","conditions":"Colorectal Surgery","enrollment":130},{"nctId":"NCT05106803","phase":"","title":"Antibiotic Profile of Pathogenic Bacteria Isolated in Public Hospitals in Northern Jordan","status":"COMPLETED","sponsor":"Yarmouk University","startDate":"2019-08-01","conditions":"Bacterial Infections, Antibiotic Resistant Infection, Surgical Site Infection","enrollment":24},{"nctId":"NCT02033408","phase":"NA","title":"Manipulating the Microbiome in IBD by Antibiotics and FMT","status":"COMPLETED","sponsor":"Shaare Zedek Medical Center","startDate":"2014-01","conditions":"Exacerbation of Ulcerative Colitis, Ulcerative Colitis, Active Severe, Crohn's Colitis","enrollment":28},{"nctId":"NCT03369093","phase":"NA","title":"RCT of Efficacy of Amoxicillin Over Ampicillin on Severe Pneumonia","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2018-01-01","conditions":"Treatment Failure, Lethargy, Altered Mental Status","enrollment":308},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT02960919","phase":"","title":"Innovative Treatments in Pneumonia (ITIP) 3","status":"COMPLETED","sponsor":"Save the Children","startDate":"2016-10-19","conditions":"Pneumonia","enrollment":1001},{"nctId":"NCT01951768","phase":"PHASE4","title":"Efficacy and Safety of Garamycin® Sponge in Diabetic Patients With a Moderate or Severe Foot Ulcer Infection","status":"COMPLETED","sponsor":"University Hospital, Geneva","startDate":"2013-09","conditions":"Diabetic Foot Ulcer","enrollment":88},{"nctId":"NCT02018094","phase":"PHASE4","title":"The Amputation Surgical Site Infection Trial (ASSIT)","status":"COMPLETED","sponsor":"Hull University Teaching Hospitals NHS Trust","startDate":"2013-10-08","conditions":"Wound Infection, Amputation Wound","enrollment":160},{"nctId":"NCT01027429","phase":"PHASE3","title":"Simplified Antibiotic Therapy for Sepsis in Young Infants","status":"COMPLETED","sponsor":"Aga Khan University","startDate":"2009-12","conditions":"Neonatal Sepsis, Sepsis, Infection","enrollment":2543},{"nctId":"NCT01333982","phase":"NA","title":"Neonatal Sepsis, Evaluation, Bangladesh","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2010-04","conditions":"Sepsis","enrollment":20000},{"nctId":"NCT00844337","phase":"NA","title":"Simplified Antibiotic Regimens for Outpatient Treatment of Suspected Sepsis in Neonates and Young Infants in Bangladesh","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2009-03","conditions":"Sepsis","enrollment":2490},{"nctId":"NCT01559753","phase":"PHASE4","title":"Early-onset Ventilator-associated Pneumonia in Adults: Comparison of 8 Versus 15 Days of Antibiotic Treatment","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"1998-01","conditions":"Pneumonia Ventilator Associated","enrollment":225}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"amoxicillin and gentamicin","genericName":"amoxicillin and gentamicin","companyName":"Aga Khan University","companyId":"aga-khan-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Amoxicillin is a beta-lactam antibiotic that inhibits cell wall synthesis in bacteria, while gentamicin is an aminoglycoside antibiotic that interferes with bacterial protein synthesis. Used for Community-acquired pneumonia, Skin and skin structure infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}